Skip to main content
BlackRock, Inc. logo

BlackRock, Inc. — Investor Relations & Filings

Ticker · BLK ISIN · US09290D1019 LEI · 529900VBK42Y5HHRMD23 US Financial and insurance activities
Open in API
Filings indexed 1,841 across all filing types
Latest filing 2026-02-04 Major Shareholding Noti…
Country US United States of America
Listing US BLK

About BlackRock, Inc.

https://www.blackrock.com/

BlackRock, Inc. is a global investment management and technology firm that provides a comprehensive range of investment, advisory, and risk management solutions. Serving both institutional and retail clients worldwide, the company manages assets across various classes, including equities, fixed income, multi-asset, and alternative investments. BlackRock is a leading provider of exchange-traded funds (ETFs) through its iShares brand. A key component of its business is the Aladdin platform, an end-to-end investment and risk management technology solution utilized internally and offered to institutional clients. The firm's investment approach integrates quantitative analysis, data science, and deep market expertise to develop diverse portfolio strategies.

Recent filings

Filing Released Lang Actions
Form 8.3 - British Land Company plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the shareholdings and dealings of BlackRock, Inc. in British Land Company plc. This type of document is specifically used to notify the market of significant shareholding changes or positions held by persons with interests in relevant securities during a takeover period. It fits the definition of a 'Major Shareholding Notification' (MRQ) as it reports ownership levels and transactions.
2026-02-04 English
Form 8.3 - Oxford Biomedica plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. This specific document details BlackRock's position and dealings in Oxford Biomedica plc. While it relates to M&A activity (Takeover Code), it is specifically a 'Major Shareholding Notification' regarding the disclosure of interests and dealings, which fits the definition of a Major Shareholding Notification (MRQ) in the provided schema.
2026-02-04 English
Form 8.3 - JTC plc
Regulatory Filings Classification · 98% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. This specific filing details BlackRock's position and dealings in JTC plc. While it involves shareholdings, it is a specific regulatory disclosure form rather than a general major shareholding notification (MRQ) or a director's dealing (DIRS). Given the nature of the Takeover Code disclosure, it falls under the category of Regulatory Filings (RNS).
2026-02-04 English
Form 8.3 - PPHE Hotel Group Limited
Regulatory Filings Classification · 98% confidence The document is a 'FORM 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more. It details shareholdings and dealings in 'PPHE Hotel Group Limited' by 'BlackRock, Inc.'. This type of filing is specifically designed to report major shareholding changes and market activity during takeover scenarios. While it involves shareholdings, it is a regulatory disclosure form rather than a simple 'Major Shareholding Notification' (MRQ) or 'Director's Dealing' (DIRS), and it is explicitly filed via an RNS (Regulatory Information Service). Given the specific regulatory nature of Form 8.3 filings in the UK, it falls under the 'Regulatory Filings' category as the most appropriate fallback for this specific type of disclosure.
2026-02-04 English
Form 8.3 - Avadel Pharmaceuticals plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure filed by BlackRock Group regarding its interests and dealings in Avadel Pharmaceuticals plc. This form is specifically required under the Irish Takeover Panel Act, 1997, and the Takeover Rules, 2022, when a person has interests in 1% or more of a company's relevant securities during a takeover period. This type of filing is a standard regulatory disclosure regarding major shareholding and dealing activity, which falls under the 'Major Shareholding Notification' category.
2026-02-04 English
Form 8.3 - Just Group plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. This specific filing by BlackRock, Inc. regarding Just Group plc details their shareholding positions and recent dealings. As it is a mandatory regulatory disclosure regarding major shareholding and takeover-related interests, it falls under the 'Major Shareholding Notification' category.
2026-02-04 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.